Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-16 Purchase | 2024-09-17 8:28 pm | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:26 pm | MBX Biosciences Inc. | MBX | BASKETT FOREST 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:24 pm | MBX Biosciences Inc. | MBX | Behbahani Ali 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:23 pm | MBX Biosciences Inc. | MBX | Chang Carmen 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:21 pm | MBX Biosciences Inc. | MBX | Florence Anthony A. Jr. 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:20 pm | MBX Biosciences Inc. | MBX | Makhzoumi Mohamad 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:18 pm | MBX Biosciences Inc. | MBX | Walker Paul Edward 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:17 pm | MBX Biosciences Inc. | MBX | Yang Rick 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:14 pm | MBX Biosciences Inc. | MBX | SANDELL SCOTT D 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:13 pm | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 750,000 | $16 | $12,000,000 | 653,787 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:12 pm | MBX Biosciences Inc. | MBX | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Direct) | View |
2024-09-16 Purchase | 2024-09-17 8:11 pm | MBX Biosciences Inc. | MBX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N 10% Owner | 625,000 | $16 | $10,000,000 | 4,552,774 (Direct) | View |
2024-09-16 Purchase | 2024-09-17 8:09 pm | MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner | 625,000 | $16 | $10,000,000 | 4,552,774 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:05 pm | MBX Biosciences Inc. | MBX | Aynechi Tiba Director | 750,000 | $16 | $12,000,000 | 2,136,335 (Indirect) | View |
2024-09-16 Purchase | 2024-09-17 8:05 pm | MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner | 750,000 | $16 | $12,000,000 | 653,787 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-09-16 Conversion | 2024-09-17 8:28 pm | N/A N/A | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:26 pm | N/A N/A | MBX Biosciences Inc. | MBX | BASKETT FOREST 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:24 pm | N/A N/A | MBX Biosciences Inc. | MBX | Behbahani Ali 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:23 pm | N/A N/A | MBX Biosciences Inc. | MBX | Chang Carmen 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:21 pm | N/A N/A | MBX Biosciences Inc. | MBX | Florence Anthony A. Jr. 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:20 pm | N/A N/A | MBX Biosciences Inc. | MBX | Makhzoumi Mohamad 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:18 pm | N/A N/A | MBX Biosciences Inc. | MBX | Walker Paul Edward 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:17 pm | N/A N/A | MBX Biosciences Inc. | MBX | Yang Rick 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:14 pm | N/A N/A | MBX Biosciences Inc. | MBX | SANDELL SCOTT D 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:13 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 39,876,501 | $0 | 653,787 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:12 pm | N/A N/A | MBX Biosciences Inc. | MBX | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 40,557,180 | $0 | 3,614,486 (Direct) | View |
2024-09-16 Conversion | 2024-09-17 8:11 pm | N/A N/A | MBX Biosciences Inc. | MBX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N 10% Owner | 51,147,891 | $0 | 4,552,774 (Direct) | View |
2024-09-16 Conversion | 2024-09-17 8:11 pm | N/A N/A | MBX Biosciences Inc. | MBX | CORNELIUS JAMES M Director | 1,329,343 | $0 | 102,082 (Direct) | View |
2024-09-16 Conversion | 2024-09-17 8:09 pm | N/A N/A | MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner | 51,147,891 | $0 | 4,552,774 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:07 pm | N/A N/A | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 5,205,750 | $0 | 879,674 (Direct) | View |
2024-09-16 Conversion | 2024-09-17 8:05 pm | N/A N/A | MBX Biosciences Inc. | MBX | Aynechi Tiba Director | 18,053,001 | $0 | 2,136,335 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:05 pm | N/A N/A | MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner | 39,876,501 | $0 | 653,787 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 7:15 pm | N/A N/A | MBX Biosciences Inc. | MBX | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner | 23,311,156 | $0 | 1,790,122 (Direct) | View |
2024-09-12 Option Award | 2024-09-13 5:19 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner | 15,963 | $0 | 15,963 (Direct) | View |
2024-09-12 Option Award | 2024-09-13 5:17 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | Ryder Steven Director | 15,963 | $0 | 15,963 (Direct) | View |
2024-09-12 Option Award | 2024-09-13 5:13 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | Bartram Richard Chief Financial Officer | 42,578 | $0 | 42,578 (Direct) | View |
2024-09-12 Option Award | 2024-09-13 5:11 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | Azoulay Salomon Chief Medical Officer | 45,011 | $0 | 45,011 (Direct) | View |
2024-09-12 Option Award | 2024-09-13 5:11 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 15,963 | $0 | 15,963 (Direct) | View |
2024-09-12 Option Award | 2024-09-13 5:06 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 120,436 | $0 | 120,436 (Direct) | View |
2024-09-12 Option Award | 2024-09-13 5:04 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | Aynechi Tiba Director | 15,963 | $0 | 15,963 (Direct) | View |
2024-09-12 Option Award | 2024-09-13 5:04 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner | 15,963 | $0 | 15,963 (Direct) | View |
2024-09-12 Option Award | 2024-09-13 5:02 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | CORNELIUS JAMES M Director | 15,963 | $0 | 15,963 (Direct) | View |
2024-09-12 Option Award | 2024-09-13 5:00 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | Pescovitz Ora H. Director | 15,963 | $0 | 15,963 (Direct) | View |
Ownership | 2024-09-12 7:52 pm | N/A N/A | MBX Biosciences Inc. | MBX | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner | 0 | $0 | 1,790,122 (Direct) | View |
Ownership | 2024-09-12 7:38 pm | N/A N/A | MBX Biosciences Inc. | MBX | Yang Rick 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |
Ownership | 2024-09-12 7:36 pm | N/A N/A | MBX Biosciences Inc. | MBX | Walker Paul Edward 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |
Ownership | 2024-09-12 7:34 pm | N/A N/A | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 0 | $0 | 1,910,632 (Direct) | View |
Ownership | 2024-09-12 7:33 pm | N/A N/A | MBX Biosciences Inc. | MBX | SANDELL SCOTT D 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |
Ownership | 2024-09-12 7:31 pm | N/A N/A | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |
Ownership | 2024-09-12 7:29 pm | N/A N/A | MBX Biosciences Inc. | MBX | Makhzoumi Mohamad 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |
Ownership | 2024-09-12 7:27 pm | N/A N/A | MBX Biosciences Inc. | MBX | Florence Anthony A. Jr. 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |
Ownership | 2024-09-12 7:26 pm | N/A N/A | MBX Biosciences Inc. | MBX | Chang Carmen 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |
Ownership | 2024-09-12 7:24 pm | N/A N/A | MBX Biosciences Inc. | MBX | Behbahani Ali 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |
Ownership | 2024-09-12 7:23 pm | N/A 2030-08-31 | MBX Biosciences Inc. | MBX | CORNELIUS JAMES M Director | 0 | $0 | 141,359 (Direct) | View |
Ownership | 2024-09-12 7:22 pm | N/A N/A | MBX Biosciences Inc. | MBX | BASKETT FOREST 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |